IGF::OT::IGF ARTIFICIAL INTELLIGENCE IN MEDICINE INC: HHSN261201500033I- TASK ORDER 2; POP 9/26/2016-9/25/2017

Artificial Intelligence In Medicine, Inc, Toronto ON

Investigators

Abstract

The purpose of this acquisition is to 1) maintain and update the existing Surveillance Epidemiology and End Results (SEER) ePath network; 2) expand the SEER network to additional pathology laboratories; 3) expand electronic data capture to include electronic reports from diagnostic imaging, and 4) install cancer data forwarding module in previously installed ePath laboratories